Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for COLL

Stock NameCollegium Pharmaceutical Inc
TickerCOLL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS19459J1043
LEI54930049FXZMTLW8D496

Show aggregate COLL holdings

News associated with COLL

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at HC Wainwright
HC Wainwright upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) to a strong-buy rating in a report released on Monday morning, MarketBeat Ratings reports. The firm currently has $44.00 target price on the specialty pharmaceutical company’s stock. COLL has been the subject of several other reports. Wall Street Zen upgraded Collegium Pharmaceutical from a […] - 2025-08-14 03:00:52
Collegium Pharmaceutical (NASDAQ:COLL) Stock Rating Upgraded by Wall Street Zen
Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Saturday. Separately, Piper Sandler reissued a “neutral” rating and set a $37.00 price objective (up previously from $36.00) on shares of Collegium Pharmaceutical […] - 2025-08-11 04:33:01
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH lifted its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 124,671 shares of the specialty pharmaceutical company’s stock after purchasing an additional 2,895 […] - 2025-07-29 05:22:58
Victory Capital Management Inc. Sells 60,823 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Victory Capital Management Inc. cut its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 10.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 498,713 shares of the specialty pharmaceutical company’s stock after selling 60,823 shares during the quarter. Victory Capital […] - 2025-07-24 04:53:18
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Bank of New York Mellon Corp
Bank of New York Mellon Corp decreased its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.1% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 242,261 shares of the specialty pharmaceutical company’s stock after selling 10,426 shares during the period. Bank of New York Mellon Corp’s holdings in Collegium Pharmaceutical were […] - 2025-07-23 04:42:46
Collegium Pharmaceutical (NASDAQ:COLL) to Repurchase $150.00 million in Outstanding Stock
Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) announced that its Board of Directors has approved a stock repurchase program on Monday, July 7th, RTT News reports. The company plans to buyback $150.00 million in outstanding shares. This buyback authorization allows the specialty pharmaceutical company to repurchase up to 15.4% of its shares through open market […] - 2025-07-09 02:16:45
Collegium Pharmaceutical Breaks Above 200-Day Moving Average - Bullish for COLL
In trading on Monday, shares of Collegium Pharmaceutical Inc (Symbol: COLL) crossed above their 200 day moving average of $31.15, changing hands as high as $31.83 per share. Collegium Pharmaceutical Inc shares are currently trading up about 4.2% on the day. The chart below sho - 2025-07-07 12:54:17
Principal Financial Group Inc. Sells 71,695 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Principal Financial Group Inc. decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,573,356 shares of the specialty pharmaceutical company’s stock after selling 71,695 shares during the quarter. Principal […] - 2025-07-07 05:54:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Illinois Municipal Retirement Fund
Illinois Municipal Retirement Fund lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 8.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,820 shares of the specialty pharmaceutical company’s stock after selling 1,384 shares during the quarter. Illinois Municipal Retirement Fund’s […] - 2025-07-04 05:19:14
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Ritholtz Wealth Management
Ritholtz Wealth Management lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 5.0% during the 1st quarter, Holdings Channel.com reports. The firm owned 32,108 shares of the specialty pharmaceutical company’s stock after selling 1,676 shares during the quarter. Ritholtz Wealth Management’s holdings in Collegium Pharmaceutical were worth $958,000 as of its most […] - 2025-06-18 05:56:50
Exchange Traded Concepts LLC Decreases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Exchange Traded Concepts LLC cut its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 16.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 62,426 shares of the specialty pharmaceutical company’s stock after selling 12,669 shares during […] - 2025-06-18 05:18:59
Farther Finance Advisors LLC Raises Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Farther Finance Advisors LLC boosted its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.5% in the first quarter, Holdings Channel.com reports. The institutional investor owned 11,091 shares of the specialty pharmaceutical company’s stock after acquiring an additional 477 shares during the period. Farther Finance Advisors LLC’s holdings in Collegium Pharmaceutical were worth […] - 2025-06-18 04:30:54
California State Teachers Retirement System Has $862,000 Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
California State Teachers Retirement System reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 30,093 shares of the specialty pharmaceutical company’s stock after selling 856 shares during the period. California State Teachers Retirement System’s holdings in Collegium Pharmaceutical were […] - 2025-06-11 05:04:51
Wellington Management Group LLP Lowers Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Wellington Management Group LLP reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 22.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 88,591 shares of the specialty pharmaceutical company’s stock after selling 26,049 shares during the period. Wellington Management Group […] - 2025-06-06 05:04:54
Bank of America Corp DE Trims Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Bank of America Corp DE decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 29.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 86,096 shares of the specialty pharmaceutical company’s stock after selling 36,093 shares during the period. Bank of America Corp DE’s holdings in Collegium Pharmaceutical were worth […] - 2025-06-02 04:38:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by ProShare Advisors LLC
ProShare Advisors LLC boosted its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 28.8% in the 4th quarter, Holdings Channel reports. The fund owned 11,196 shares of the specialty pharmaceutical company’s stock after acquiring an additional 2,506 shares during the quarter. ProShare Advisors LLC’s holdings in Collegium Pharmaceutical were worth $321,000 […] - 2025-05-30 05:06:52
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $43.80 Average Price Target from Brokerages
Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five ratings firms that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price […] - 2025-05-21 03:14:51
Voya Investment Management LLC Cuts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Voya Investment Management LLC lessened its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 7.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,923 shares of the specialty pharmaceutical company’s stock after selling 789 shares during the period. Voya […] - 2025-05-13 04:32:48
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stake Reduced by Hsbc Holdings PLC
Hsbc Holdings PLC decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 3.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 16,879 shares of the specialty pharmaceutical company’s stock after selling 576 shares during the period. Hsbc Holdings PLC’s holdings in Collegium Pharmaceutical were worth $483,000 at the end […] - 2025-05-07 05:00:51
Barclays PLC Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Barclays PLC increased its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 6.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 79,754 shares of the specialty pharmaceutical company’s stock after purchasing an additional 4,702 shares during the […] - 2025-05-01 05:14:59
Raymond James Financial Inc. Buys New Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Raymond James Financial Inc. bought a new stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 84,883 shares of the specialty pharmaceutical company’s stock, valued at approximately $2,432,000. Other hedge funds and […] - 2025-04-30 05:10:55
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Legal & General Group Plc
Legal & General Group Plc lessened its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 1.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 91,309 shares of the specialty pharmaceutical company’s stock after selling 1,084 shares during the period. Legal & General Group Plc’s holdings in Collegium Pharmaceutical were […] - 2025-04-24 06:31:01
Russell Investments Group Ltd. Decreases Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Russell Investments Group Ltd. reduced its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 31.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,649 shares of the specialty pharmaceutical company’s stock after selling 6,223 shares […] - 2025-04-24 04:48:48
JPMorgan Chase & Co. Cuts Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
JPMorgan Chase & Co. lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 70.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 82,691 shares of the specialty pharmaceutical company’s stock after selling 194,513 shares during the […] - 2025-04-24 04:16:59
Collegium Pharmaceutical (NASDAQ:COLL) Rating Lowered to Buy at StockNews.com
Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday. A number of other analysts also recently weighed in on the stock. Needham & Company LLC reissued a “buy” rating and set a […] - 2025-04-21 02:22:45
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Bought by Invesco Ltd.
Invesco Ltd. grew its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 19.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,775,760 shares of the specialty pharmaceutical company’s stock after acquiring an additional 289,335 shares during the quarter. Invesco Ltd. owned about […] - 2025-04-16 04:47:00
Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at StockNews.com
StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a research report report published on Friday morning. A number of other equities research analysts also recently weighed in on COLL. Needham & Company LLC reaffirmed a “buy” rating and issued a $46.00 target price on […] - 2025-04-14 02:58:57
Vanguard Group Inc. Sells 63,876 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Vanguard Group Inc. cut its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,282,666 shares of the specialty pharmaceutical company’s stock after selling 63,876 shares during the period. Vanguard Group Inc. […] - 2025-04-11 06:16:58
Corebridge Financial Inc. Sells 1,595 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
Corebridge Financial Inc. lowered its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 8.5% during the 4th quarter, HoldingsChannel reports. The fund owned 17,084 shares of the specialty pharmaceutical company’s stock after selling 1,595 shares during the period. Corebridge Financial Inc.’s holdings in Collegium Pharmaceutical were worth $489,000 as of its […] - 2025-04-09 04:38:48
American Century Companies Inc. Has $2.45 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
American Century Companies Inc. trimmed its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 18.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 85,466 shares of the specialty pharmaceutical company’s stock after selling 19,447 […] - 2025-04-08 05:04:48

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc COLL holdings

DateNumber of COLL Shares HeldBase Market Value of COLL SharesLocal Market Value of COLL SharesChange in COLL Shares HeldChange in COLL Base ValueCurrent Price per COLL Share HeldPrevious Price per COLL Share Held
2025-11-12 (Wednesday)4,255COLL holding decreased by -14USD 201,474COLL holding increased by 10052USD 201,474-14USD 10,052 USD 47.3499 USD 44.84
2025-11-11 (Tuesday)4,269USD 191,422COLL holding increased by 5592USD 191,4220USD 5,592 USD 44.84 USD 43.5301
2025-11-10 (Monday)4,269USD 185,830COLL holding increased by 5251USD 185,8300USD 5,251 USD 43.5301 USD 42.3001
2025-11-07 (Friday)4,269USD 180,579COLL holding increased by 7001USD 180,5790USD 7,001 USD 42.3001 USD 40.6601
2025-11-06 (Thursday)4,269COLL holding decreased by -14USD 173,578COLL holding increased by 20032USD 173,578-14USD 20,032 USD 40.6601 USD 35.8501
2025-11-05 (Wednesday)4,283COLL holding decreased by -140USD 153,546COLL holding decreased by -4620USD 153,546-140USD -4,620 USD 35.8501 USD 35.7599
2025-11-04 (Tuesday)4,423COLL holding decreased by -28USD 158,166COLL holding decreased by -2515USD 158,166-28USD -2,515 USD 35.7599 USD 36.1
2025-11-03 (Monday)4,451COLL holding decreased by -28USD 160,681COLL holding decreased by -563USD 160,681-28USD -563 USD 36.1 USD 36
2025-10-31 (Friday)4,479USD 161,244COLL holding increased by 1568USD 161,2440USD 1,568 USD 36 USD 35.6499
2025-10-30 (Thursday)4,479USD 159,676COLL holding increased by 3762USD 159,6760USD 3,762 USD 35.6499 USD 34.81
2025-10-29 (Wednesday)4,479USD 155,914COLL holding decreased by -2687USD 155,9140USD -2,687 USD 34.81 USD 35.4099
2025-10-28 (Tuesday)4,479COLL holding increased by 42USD 158,601COLL holding increased by 4127USD 158,60142USD 4,127 USD 35.4099 USD 34.815
2025-10-27 (Monday)4,437USD 154,474COLL holding decreased by -2152USD 154,4740USD -2,152 USD 34.815 USD 35.3
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of COLL by Blackrock for IE00B3VWM098

Show aggregate share trades of COLL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12SELL-1447.50045.000 45.250USD -634 31.02 Loss of -199 on sale
2025-11-06SELL-1441.81039.080 39.353USD -551 30.78 Loss of -120 on sale
2025-11-05SELL-14036.58035.255 35.387USD -4,954 30.75 Loss of -649 on sale
2025-11-04SELL-2836.54035.620 35.712USD -1,000 30.73 Loss of -140 on sale
2025-11-03SELL-2836.57535.330 35.455USD -993 30.70 Loss of -133 on sale
2025-10-28BUY4235.41035.815 35.774USD 1,503 30.59
2025-10-24SELL-1435.30035.970 35.903USD -503 30.55 Loss of -75 on sale
2025-10-15BUY8432.88033.000 32.988USD 2,771 30.39
2025-10-02BUY1434.28035.305 35.203USD 493 30.34
2025-09-30BUY2834.99035.535 35.481USD 993 30.29
2025-08-21SELL-1439.52039.530 39.529USD -553 30.12 Loss of -132 on sale
2025-07-31BUY4229.86030.680 30.598USD 1,285 30.08
2025-06-30SELL-2829.57030.150 30.092USD -843 29.91 Loss of -5 on sale
2025-06-25SELL-1429.79030.230 30.186USD -423 29.91 Loss of -4 on sale
2025-06-20SELL-2829.83029.970 29.956USD -839 29.91 Loss of -1 on sale
2025-05-23BUY1428.86028.990 28.977USD 406 29.98
2025-05-19SELL-1429.83030.160 30.127USD -422 30.00 Loss of -2 on sale
2025-05-15SELL-4229.34029.800 29.754USD -1,250 30.00 Profit of 11 on sale
2025-05-12SELL-1429.56030.460 30.370USD -425 30.02 Loss of -5 on sale
2025-05-09SELL-1428.89029.660 29.583USD -414 30.03 Profit of 6 on sale
2025-04-30SELL-1426.99527.539 27.485USD -385 30.22 Profit of 38 on sale
2025-04-24SELL-2826.78026.940 26.924USD -754 30.35 Profit of 96 on sale
2025-04-17SELL-1427.01027.775 27.698USD -388 30.54 Profit of 40 on sale
2025-04-15SELL-4227.12027.570 27.525USD -1,156 30.61 Profit of 130 on sale
2025-04-14SELL-4226.73027.190 27.144USD -1,140 30.65 Profit of 147 on sale
2025-04-09SELL-5626.37026.822 26.777USD -1,500 30.82 Profit of 226 on sale
2025-04-07SELL-9827.38028.365 28.266USD -2,770 30.92 Profit of 260 on sale
2025-04-04SELL-14028.14028.340 28.320USD -3,965 30.96 Profit of 369 on sale
2025-03-31BUY1429.85030.200 30.165USD 422 31.00
2025-03-19SELL-2829.85030.000 29.985USD -840 31.11 Profit of 32 on sale
2025-03-14SELL-8429.46030.010 29.955USD -2,516 31.17 Profit of 102 on sale
2025-03-13SELL-2829.10029.910 29.829USD -835 31.20 Profit of 38 on sale
2025-03-12SELL-47629.63029.910 29.882USD -14,224 31.23 Profit of 640 on sale
2025-03-07SELL-2828.91030.010 29.900USD -837 31.30 Profit of 39 on sale
2025-03-06SELL-4229.80030.020 29.998USD -1,260 31.33 Profit of 56 on sale
2025-03-03SELL-1428.44029.630 29.511USD -413 31.47 Profit of 27 on sale
2025-02-28SELL-8429.05031.440 31.201USD -2,621 31.51 Profit of 26 on sale
2025-02-26SELL-1428.35029.500 29.385USD -411 31.62 Profit of 31 on sale
2025-02-25SELL-4228.82029.400 29.342USD -1,232 31.67 Profit of 98 on sale
2025-02-18BUY7029.71030.140 30.097USD 2,107 31.87
2025-02-13BUY1430.98031.050 31.043USD 435 31.97
2025-02-12BUY1430.53031.530 31.430USD 440 32.00
2025-02-11BUY4231.58031.710 31.697USD 1,331 32.01
2025-02-06BUY12630.95031.520 31.463USD 3,964 32.10
2025-01-27BUY1433.91034.000 33.991USD 476 32.10
2024-12-30BUY7028.61029.100 29.051USD 2,034 32.30
2024-12-06BUY5629.97030.510 30.456USD 1,706 32.51
2024-12-05BUY1429.87031.070 30.950USD 433 32.60
2024-12-04BUY7031.12031.340 31.318USD 2,192 32.65
2024-11-29BUY7030.50031.110 31.049USD 2,173 32.87
2024-11-27BUY5630.71031.700 31.601USD 1,770 33.06
2024-11-26BUY1431.19031.660 31.613USD 443 33.15
2024-11-21BUY7030.41030.950 30.896USD 2,163 33.58
2024-11-20BUY4230.00030.030 30.027USD 1,261 33.78
2024-11-18BUY16829.22029.780 29.724USD 4,994 34.32
2024-11-12BUY11231.41032.180 32.103USD 3,596 34.51
2024-11-08BUY7032.16034.110 33.915USD 2,374 34.68
2024-11-07BUY21034.71035.620 35.529USD 7,461 34.68
2024-11-06BUY2834.50035.570 35.463USD 993 34.69
2024-10-31BUY1434.14034.640 34.590USD 484 35.32
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of COLL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1961,020088,70668.8%
2025-09-1841,541067,79461.3%
2025-09-1766,6180114,34758.3%
2025-09-16133,1610194,29868.5%
2025-09-15152,5510212,47871.8%
2025-09-1295,1360129,59873.4%
2025-09-11110,4230246,76444.7%
2025-09-1053,467099,00754.0%
2025-09-09109,5130233,49346.9%
2025-09-08206,3772311,09166.3%
2025-09-0578,1370150,74951.8%
2025-09-0464,0066,972105,81160.5%
2025-09-0363,5930122,60051.9%
2025-09-02101,0850159,73063.3%
2025-08-2946,4330126,23536.8%
2025-08-2851,923097,38753.3%
2025-08-2731,315075,37041.5%
2025-08-2640,9300153,66426.6%
2025-08-2556,6700122,83746.1%
2025-08-2235,5630123,46528.8%
2025-08-2136,265085,49942.4%
2025-08-2049,3641588,02056.1%
2025-08-1963,10950120,93652.2%
2025-08-1829,505092,25532.0%
2025-08-1520,662064,21132.2%
2025-08-1487,4240118,48173.8%
2025-08-1349,95814132,12337.8%
2025-08-1291,8240151,45160.6%
2025-08-11129,8833,211250,03551.9%
2025-08-0883,3940319,66326.1%
2025-08-07193,6760339,68757.0%
2025-08-0698,2330169,42058.0%
2025-08-0532,115070,96745.3%
2025-08-0436,300070,24351.7%
2025-08-01102,2750172,38059.3%
2025-07-3135,405066,55753.2%
2025-07-3021,992061,11236.0%
2025-07-2926,689072,67636.7%
2025-07-2822,692082,91327.4%
2025-07-2530,500069,12644.1%
2025-07-2426,485068,76738.5%
2025-07-2324,505067,62536.2%
2025-07-2241,4461,00484,38149.1%
2025-07-2132,627070,69346.2%
2025-07-1826,5881456,89546.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.